P116: Noninvasive markers of central and musculoskeletal symptoms in infantile- and late-onset Pompe disease*
Raquel van Gool(Boston Children's Hospital), Jaymin Upadhyay(Boston Children's Hospital), Jason A. Tourville(Boston University), Buket Sonbas Cobb(Beth Israel Deaconess Medical Center), Carlos Camelo(Boston Children's Hospital), Amanda Cao(Boston Children's Hospital), Vanessa Rameh(Boston Children's Hospital), Adam P. Vogel(Synlab Czech (Czechia)), Mark Walterfang(Edith Cowan University), Hanne van der Heijden(Boston Children's Hospital), Benjamin D. Goodlett(Boston Children's Hospital), Olaf A. Bodamer(Broad Institute), Seward B. Rutkove(Beth Israel Deaconess Medical Center), Chantal Akkari(Boston Children's Hospital), David Kronn(New York Medical College), Lise Vrolix(Boston Children's Hospital), Walla Al-Hertani(Children's Hospital of Orange County), Jennie Grammer(University of California, Los Angeles), Margot Valerie Stein(New York Medical College), Hawa Sakho(New York Medical College), Nick Todd(Brigham and Women's Hospital), Nehal Shah(Brigham and Women's Hospital), Georgina Johnson(The University of Melbourne), Julie Shulman(Boston Children's Hospital)
Cited by 0
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Recommendations for the diagnosis and management of Niemann–Pick disease type C: An update
|Molecular Genetics and Metabolism|2012|478
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
|Nature Communications|2016|326
Phenylketonuria Scientific Review Conference: State of the science and future research needs
|Molecular Genetics and Metabolism|2014|271